Twist Bioscience Corp — Director's Dealing 2020

Jul 10, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2020-07-07

Reporting Person: Finn Patrick John (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-07-07	Common Stock	S	15264	$47.0333	Disposed	11097	Direct
2020-07-07	Common Stock	S	820	$48.4653	Disposed	10277	Direct
2020-07-08	Common Stock	M	28820	$26.66	Acquired	39097	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-07-08	Employee Stock Option (right to buy)	$26.66	M	28820	Disposed	2028-11-18	Common Stock (28820)	Direct

Footnotes

F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 22, 2019.

F2: Represents the weighted average sales price per share. The shares sold at prices ranging from $46.66 to $47.64 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F3: Represents the weighted average sales price per share. The shares sold at prices ranging from $48.10 to $48.84 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F4: 12/60th of the shares subject to the option vest and become exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.